K2X Technology & Life Science, Inc.
KBPH
OTC PK
| 12/31/2021 | 09/30/2021 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -8.40% | -35.81% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 11.41% | 11.69% | |||
| Total Operating Expenses | 5.39% | -8.82% | |||
| Operating Income | -5.39% | 8.82% | |||
| Income Before Tax | -67.85% | 398.41% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -67.85% | 398.41% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -67.85% | 398.41% | |||
| EBIT | -5.39% | 8.82% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -81.09% | 398.02% | |||
| Normalized Basic EPS | -4.79% | 8.24% | |||
| EPS Diluted | -75.00% | 258.73% | |||
| Normalized Diluted EPS | -22.22% | 55.49% | |||
| Average Basic Shares Outstanding | 0.12% | 0.02% | |||
| Average Diluted Shares Outstanding | -13.98% | 106.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
